Patient presents with symptoms suggestive of non-ischemic cardiomyopathy (NICM), including dyspnea on exertion, fatigue, and lower extremity edema.  The patient reports a progressive decline in functional capacity over the past [timeframe, e.g., six months].  Physical examination reveals jugular venous distension, S3 gallop, and bibasilar crackles.  The patient denies a history of myocardial infarction, significant coronary artery disease, or valvular heart disease.  Electrocardiogram (ECG) demonstrates [ECG findings, e.g., sinus rhythm with left ventricular hypertrophy].  Transthoracic echocardiogram (TTE) reveals [TTE findings, e.g., left ventricular dilation with reduced ejection fraction (LVEF) of [percentage]].  Laboratory results show [lab values, e.g., elevated BNP and NT-proBNP]. Based on the clinical presentation, diagnostic imaging, and laboratory findings, the diagnosis of dilated cardiomyopathy, a type of non-ischemic cardiomyopathy, is established.  Differential diagnosis includes ischemic cardiomyopathy, restrictive cardiomyopathy, hypertrophic cardiomyopathy, and myocarditis.  Ischemic etiology was ruled out based on negative cardiac catheterization or coronary computed tomography angiography (CCTA) findings [if applicable]. The patient was counseled on lifestyle modifications, including sodium restriction and fluid management.  Pharmacological management initiated includes diuretics, beta-blockers, and ACE inhibitors as indicated for heart failure management.  Cardiac resynchronization therapy (CRT) and implantable cardioverter-defibrillator (ICD) will be considered based on disease progression and guideline-directed medical therapy (GDMT) response.  Close monitoring of cardiac function and symptoms is recommended, with follow-up scheduled in [timeframe, e.g., four weeks].


Patient presents with complaints of palpitations and pre-syncope, raising suspicion for non-ischemic cardiomyopathy.  Physical examination is notable for irregular heart rhythm.  Electrocardiogram reveals [ECG findings, e.g., atrial fibrillation].  Echocardiography shows [TTE findings, e.g., normal left ventricular size and systolic function with evidence of diastolic dysfunction].  Cardiac biomarkers are within normal limits.  The patient’s history is significant for [risk factors, e.g., hypertension, diabetes, obesity].  Given the constellation of findings, a diagnosis of hypertrophic cardiomyopathy (HCM), a form of non-ischemic cardiomyopathy, is considered.  Differential diagnoses include other causes of palpitations and syncope.  Further evaluation with cardiac magnetic resonance imaging (CMRI) is recommended to assess for myocardial thickening and fibrosis characteristic of HCM.  Genetic testing may be considered for familial HCM screening.  Treatment options, including beta-blockers and calcium channel blockers, to manage heart rate and symptoms will be discussed.  The patient will be educated on the importance of avoiding strenuous exercise and dehydration.  Referral to a cardiologist specializing in HCM management is warranted.  Follow-up appointment is scheduled in [timeframe, e.g., two weeks].